[1]
P. Scolieri et al., “Retention rate of upadacitinib therapy in rheumatoid arthritis: Results of a large Italian multicenter real-world study”, Rheumatol Bul, vol. 32, no. 1, pp. 22–29, Jun. 2024, doi: 10.35465/32.1.2024.pp22-29.